Keyphrases
Isoflurane
57%
Anesthetic Neurotoxicity
48%
Brain Development
44%
Anesthetics
44%
General Anesthetics
28%
Mammalian Target of Rapamycin (mTOR)
23%
Rapamycin
22%
Developmental Exposure
21%
Chronic Pain
18%
MTOR Pathway
18%
Early-life Exposure
18%
Cognitive Deficits
16%
General Anesthetic Agents
13%
Semaphorin3A
12%
Neuronal Development
12%
Early Postnatal Period
12%
General Anesthesia
12%
Target of Rapamycin Pathway
11%
Rat Cortical Neurons
10%
Primary Neuronal Culture
10%
Axon Outgrowth
10%
Axon Branching
10%
Sedative
10%
Rodent Models
10%
Signaling Pathway
10%
Neurodevelopment
10%
Signaling System
9%
Anesthetic Exposure
9%
Neurogenesis
9%
Microvascular Decompression
9%
Volatile Anesthetics
9%
Expert Opinion
9%
Preclinical Research
9%
Behavior Modification
9%
Neocortical Neurons
9%
Microbiome
9%
Sedation Monitoring
9%
L1 Cell Adhesion Molecule (L1CAM)
9%
Invasive Blood Pressure Monitoring
9%
NIGMS
9%
Molecular Mechanism
9%
Sedation
9%
Radixin
9%
Moesin
9%
Intestinal Microbiome
9%
Expired Gas
9%
Astrocytes
9%
Synaptic Remodeling
9%
Synapse Formation
9%
Metabolic Analyzer
9%
Neuroscience
Anesthetics
100%
Isoflurane
67%
Axon
42%
Growth Cone
34%
Eicosanoid Receptor
28%
Neurotoxicity
25%
Brain Development
25%
Mammalian Target of Rapamycin
19%
Semaphorin
19%
Nerve Cell Differentiation
18%
Hippocampus
17%
Neural Development
14%
Synapse
13%
Cognitive Disorders
13%
Cell Adhesion Molecule
13%
In Vitro
12%
Neurogenesis
12%
Ezrin
11%
Radixin
11%
Moesin
11%
Gamma-Aminobutyric Acid
10%
Immunohistochemistry
9%
Midazolam
9%
Ankyrin
9%
Acid Protein
9%
Axon Guidance
9%
Sevoflurane
9%
Neuropathic Pain
9%
Neural Stem Cell
9%
Neuroprotection
9%
Cell Damage
9%
Astrocyte
9%
Nerve Cell Adhesion Molecule L1
9%
Pervasive Developmental Disorder
9%
Dentate Gyrus
8%
Actin
6%
Neurite Outgrowth
6%
Neuron-Specific Enolase
6%
Postoperative Cognitive Dysfunction
6%
Central Nervous System
5%
GABA Receptor
5%
In Vivo
5%
Dendrite
5%